SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-008171
Filing Date
2017-07-26
Accepted
2017-07-26 09:00:29
Documents
10
Period of Report
2017-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 42729
2 ex4-1.htm EX-4.1 146614
3 ex4-2.htm EX-4.2 140377
4 ex4-3.htm EX-4.3 140609
5 ex4-4.htm EX-4.4 144791
6 ex10-1.htm EX-10.1 60598
7 ex10-2.htm EX-10.2 65303
8 ex10-3.htm EX-10.3 61017
9 ex99-1.htm EX-99.1 11515
10 image_001.jpg GRAPHIC 10688
  Complete submission text file 0001493152-17-008171.txt   829632
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 17981759
SIC: 2835 In Vitro & In Vivo Diagnostic Substances